153 Results for "

mitosis

" in MedChemExpress (MCE) Product Catalog:
Products (153)

153 Results for "mitosis" in MCE Product Catalog:

128
128 Publications Verification
Cat. No.: HY-13520
CAS No.: 31430-18-9
Purity:  99.59%
Synonyms: Oncodazole; R17934
Research Areas:  

Cancer

Nocodazole (Oncodazole) is a rapidly-reversible inhibitor of microtubule. Nocodazole binds to β-tubulin and disrupts microtubule assembly/disassembly dynamics, which prevents mitosis and induces apoptosis in tumor cells. Nocodazole inhibits Bcr-Abl.
loading...
    loading...
28
28 Cited Publications
Cat. No.: HY-19792
CAS No.: 139504-50-0
Synonyms: DM1; Maytansinoid DM1
Research Areas:  

Cancer

Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. Mertansine can be attached to a monoclonal antibody with a linker to create an antibody-drug conjugate (ADC) .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-13032B
CAS No.: 1895049-20-3
Purity:  97.04%
Synonyms: GSK 525762C; I-BET 762 besylate
Research Areas:  

Cancer

Molibresib besylate (GSK 525762C; I-BET 762 besylate) is an orally active pan-BET inhibitor that targets and binds to BRD2, BRD3, BRD4 and BRDT. By competitively occupying acetylated lysine binding sites, Molibresib besylate disrupts the interaction between BET proteins and chromatin, thereby effectively inhibiting MYC expression and target gene transcription. Molibresib besylate exhibits broad antiproliferative activity, which not only inhibits cancer cell growth and induces growth arrest, but also downregulates mitosis-related genes and upregulates the level of p-ERK1/2. When combined with MEK inhibitors, Molibresib besylate shows a significant synergistic effect, reduces tumor burden in mouse models of leukemia, modulates the immune microenvironment and prolongs survival. Molibresib besylate is widely applicable to research related to acute myeloid leukemia, multiple myeloma, triple-negative breast cancer, small-cell lung cancer and various advanced refractory solid tumors .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-110287
CAS No.: 300815-04-7
Purity:  99.62%
Target:  

APC Mitosis

Research Areas:  

Cancer

Apcin, a ligand of Cdc20, is a potent and competitive anaphase-promoting complex/cyclosome (APC/C(Cdc20)) E3 ligase activity inhibitor. Apcin competitively inhibits APC/C-dependent ubiquitylation by binding to Cdc20 and preventing substrate recognition. Apcin occupes the D-box-binding pocket on the side face of the WD40-domain and can prolong mitosis .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-115576
CAS No.: 1809031-84-2
Purity:  99.54%
Research Areas:  

Neurological Disease Cancer

P62-mediated mitophagy inducer (PMI) is a P62-mediated mitophagy activator. P62-mediated mitophagy inducer activates mitochondrial autophagy without recruitment of Parkin or collapse of the mitochondrial membrane potential and remains active in cells lacking a fully functional PINK1/Parkin pathway. P62-mediated mitophagy inducer serves as a pharmacological tool to study the molecular mechanisms of mitosis, avoiding toxicity and some of the non-specific effects associated with the sudden dissipation of mitochondria lacking membrane potential .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-112136
CAS No.: 850467-66-2
Purity:  99.81%
Synonyms: CP 43
Target:  

MAP3K Mitosis

Research Areas:  

Cancer

TAO Kinase inhibitor 1 (compound 43) is a selective, ATP-competitive thousand-and-one amino acid kinases (TAOK) inhibitor with IC50s of 11 to 15 nM for TAOK1 and 2, respectively. TAO Kinase inhibitor 1 delays mitosis and induces mitotic cell death .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107614
CAS No.: 325465-93-8
Purity:  99.80%
Synonyms: 1-Oleoyl-sn-glycero-3-phosphate sodium; 1-Oleoyl-LPA sodium
Target:  

LPL Receptor Mitosis

Research Areas:  

Neurological Disease

1-Oleoyl lysophosphatidic acid (1-Oleoyl-sn-glycero-3-phosphate) sodium, a potent bioactive phospholipid, is a LPA receptor activator. 1-Oleoyl lysophosphatidic acid sodium can promote mitosis by inducing DNA synthesis. 1-Oleoyl lysophosphatidic acid sodium is also involved in normal and pathological emotional responses, including anxiety and depression .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100789
CAS No.: 1312471-39-8
Purity:  99.90%
Research Areas:  

Cancer

ON1231320 is a highly specific polo like kinase 2 (PLK2) inhibitor with an IC50 of 0.31 μM. ON1231320 blocks tumor cell cycle progression in the G2/M phase in mitosis, causing apoptotic cell death. ON1231320, an arylsulfonyl pyrido-pyrimidinone, has antitumor activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108330
CAS No.: 118409-62-4
Purity:  ≥98.0%
Synonyms: Tyrphostin AG126
Target:  

ERK Mitosis

Research Areas:  

Inflammation/Immunology

AG126 is a tyrosine kinase inhibitor, can inhibit the phosphorylation of ERK1 and ERK2 at 25-50 μM. AG126 can be used in meiosis, mitosis, and postmitotic research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100368
CAS No.: 1922153-17-0
Purity:  98.32%
Synonyms: NVS-MELK8a
Research Areas:  

Cancer

MELK-8a (NVS-MELK8a) is a highly potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor with IC50 of 2 nM. MELK-8a also inhibits Flt3 (ITD), Haspin, PDGFRα with IC50s of 0.18, 0.19, and 0.42 μM, respectively. MELK plays an essential role in regulating cell mitosis in a subset of cancer cells .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15160
CAS No.: 1137868-52-0
Purity:  99.75%
Research Areas:  

Cancer

TAK-960 is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM. TAK-960 also shows inhibitory activities against PLK2 and PLK3, with IC50s of 16.9 and 50.2 nM, respectively. TAK-960 inhibits proliferation of multiple cancer cell lines and exhibits significant efficacy against multiple tumor xenografts .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14846
CAS No.: 910634-41-2
Purity:  99.35%
Synonyms: LY2523355
Target:  

Kinesin Mitosis

Research Areas:  

Cancer

Litronesib (LY2523355) is a selective mitosis-specific kinesin Eg5 inhibitor, with antitumor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-D1746
CAS No.: 162303-59-5
Synonyms: EDTA acetoxymethyl ester; Ethylenediaminetetraacetic acid acetoxymethyl ester
EDTA-AM (ethylenediaminetetraacetic acid, acetoxymethyl ester) is the membrane-permeant form of the metal chelator EDTA (HY-Y0682). Live cells passively load EDTA-AM by incubating with EDTA-AM. Once internalized, cytoplasmic esterase decomposes AM esters, releasing the active ligand EDTA, which isolates metal ions within the cell. EDTA-AM induces an arrest of mitotic progression and chromosome decondensation .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-136369
CAS No.: 26225-79-6
Purity:  95.31%
Research Areas:  

Others

Ethofumesate, a chiral herbicide, acts by inhibiting mitosis and reducing photosynthesis and plant respiration .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15160B
Purity:  99.19%
Research Areas:  

Cancer

TAK-960 dihydrochloride is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM. TAK-960 dihydrochloride also shows inhibitory activities against PLK2 and PLK3, with IC50s of 16.9 and 50.2 nM, respectively. TAK-960 dihydrochloride inhibits proliferation of multiple cancer cell lines and exhibits significant efficacy against multiple tumor xenografts .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145967
CAS No.: 2413991-74-7
Purity:  98.03%
Target:  

Deubiquitinase Mitosis

Research Areas:  

Cancer

FT709 is a potent and selective USP9X inhibitor, an IC50 of 82 nM. USP9X has been linked with centrosome function, chromosome alignment during mitosis, EGF receptor degradation, chemo-sensitization, and circadian rhythms .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107811
CAS No.: 487-03-6
Purity:  99.76%
Harmol is an orally active β-carboline alkaloid. Harmol is a TFEB activator and monoamine oxidase inhibitor. Harmol can induce cell mitosis, Autophagy and Apoptosis. Harmol promotes the degradation of α-synuclein by regulating the autophagy-lysosomal pathway. Harmol has anti-tumor, anti-depressant and anti-aging activities. Harmol improves motor impairment in a mouse Parkinson's disease model .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13627
CAS No.: 52205-73-9
Purity:  99.42%
Estramustine phosphate sodium, an estradiol analog, is an orally active antimicrotubule chemotherapy agent. Estramustine phosphate sodium depolymerises microtubules by binding to microtubule associated proteins (MAPs) and/or to tubulin. Estramustine phosphate sodium can interfere mitosis, trigger cell death and induce apoptosis, which can be used for the research of cancer like prostate cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103711
CAS No.: 2998-57-4
Purity:  99.15%
Research Areas:  

Cancer

Estramustine, an estradiol analog, is an orally active antimicrotubule chemotherapy agent. Estramustine depolymerises microtubules by binding to microtubule associated proteins (MAPs) and/or to tubulin. Estramustine can interfere mitosis, trigger cell death and induce apoptosis, which can be used for the research of cancer like prostate cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13737
CAS No.: 882531-87-5
Purity:  98.29%
Target:  

Apoptosis VEGFR FGFR Mitosis

Research Areas:  

Cancer

R1530 is a highly potent, orally active, dual-acting mitosis/angiogenesis inhibitor, with anti-tumor and anti-angiogenic activities. R1530 is a multikinase inhibitor which binds to 31 kinases with Kd values of <500 nM. R1530 inhibits VGFR2 and FGFR1 with IC50 of 10 nM and 28 nM, respectively. R1530 triggers apoptosis (mitotic catastrophe) or senescence .
loading...
    loading...